Evidence map›Paper›PMID 26104582›Full record

ArticleBMC complementary and alternative medicine2015

Effects of Ixeris dentata water extract and caffeic acid on allergic inflammation in vivo and in vitro.

Yong-Deok Jeon, Ji-Ye Kee, Dae-Seung Kim, Yo-Han Han, Sung-Hoon Kim, Su-Jin Kim, Jae-Young Um, Seung-Heon Hong

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Neuroprotective Effect ofCurrent issues in molecular biology · 2024
    Article
  6. The immunomodulatory activity ofJournal of Taibah University Medical Sciences · 2024
    Article
  7. Article
  8. Molecular medicine reports · 2021
    Article
  9. Article
  10. Nutrients · 2020
    Article
  11. Inhibitory Effects ofAntioxidants (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Article
  14. Potential Application ofNutrients · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yong-Deok JeonDepartment of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Jeonbuk, 570-749, Republic of Korea.
Ji-Ye KeeDepartment of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Jeonbuk, 570-749, Republic of Korea.
Dae-Seung KimDepartment of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Jeonbuk, 570-749, Republic of Korea.
Yo-Han HanDepartment of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Jeonbuk, 570-749, Republic of Korea.
Sung-Hoon KimCollege of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
Su-Jin KimDepartment of Cosmeceutical Science, Daegu Hanny University, Yugok-dong, Kyungsan, 712-715, Republic of Korea.
Jae-Young UmCollege of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea. jyum@khu.ac.kr.
Seung-Heon HongDepartment of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Jeonbuk, 570-749, Republic of Korea. jooklim@wku.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIxeris dentata Nakai has been used for the treatment of mithridatism, calculous, indigestion, pneumonia, hepatitis, and tumors in Korea, China, and Japan. However, the effect of a water extract of Ixeris dentata (ID) and its molecular mechanism on allergic inflammation has not been elucidated. In this study, we attempted to evaluate the effects of ID and its major compound caffeic acid on allergic inflammation in vivo and in vitro.

methodsID was applied to 2, 4-dinitrofluorobenzene (DNFB)-induced atopic dermatitis (AD)-like skin lesion mice and immune cell infiltration, cytokine production, and the activation of mitogen-activated protein kinases (MAPKs) were investigated. Moreover, the effect of ID on compound 48/80-induced anaphylactic shock was investigated in a mouse model. The human keratinocyte cell line (HaCaT cells) and human mast cells (HMC-1) were treated with ID or caffeic acid to investigate the effects on the production of chemokines and proinflammatory cytokines and on the activation of MAPKs.

resultsID inhibited the serum levels of IgE and interleukin (IL)-1β in DNFB-induced AD-like skin lesion mouse models and suppressed anaphylactic shock in the mouse models. ID and caffeic acid inhibited the production of chemokines and adhesion molecules in HaCaT cells. In addition, ID reduced the release of tumor necrosis factor-α and IL-8 via the inhibition of MAPKs phosphorylation in HMC-1 cells.

conclusionsThese results suggest that ID is a potential therapeutic agent for allergic inflammatory diseases, including dermatitis.

Indexed as

Signal TransductionAnimalsAsteraceaeCaffeic AcidsCell LineHumansInflammationMicePlant Extractscaffeic acidCaffeic AcidsPlant Extracts

Identifiers

PMID26104582
PMCPMC4479232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.